Sulfapyridine

Sulfapyridine, sulfapyridine, 144-83-2, Sulphapyridine, 2-Sulfapyridine, 2-Sulfanilamidopyridine, Coccoclase, Dagenan, Eubasin, Piridazol, Sulfidin, Sulfidine, Streptosilpyridine, Eubasinum, Haptocil, Plurazol, Pyriamid, Pyridazol, 2-Sulfanilylaminopyridine, Relbapiridina, Septipulmon, Thioseptal, Adiplon, Trianon, Ronin, Sulfapiridina, 2-Sulfanilamidopyridin, N-2-Pyridylsulfanilamide, Solfapiridina, Sulfapyridinum, Benzenesulfonamide, 4-amino-N-2-pyridinyl-, 4-amino-N-pyridin-2-ylbenzenesulfonamide, N(sup 1)-2-Pyridylsulfanilamide, 2-(p-Aminobenzenesulphonamido)pyridine, 2-Sulfanilyl aminopyridine, 4-amino-N-pyridin-2-yl-benzenesulfonamide, 4-(2-Pyridinylsulfonyl)aniline, M&B 693, M+B 693, 4-amino-N-(pyridin-2-yl)benzene-1-sulfonamide, 4-[(2-Pyridylamino)sulfonyl]aniline, Sulfanilamide, N1-2-pyridyl-, A-499, N(1)-Pyridylsulfanilamide, N(1)-2-Pyridylsulfanilamide, Sulfanilamide, N(sup 1)-2-pyridyl-, DTXSID3026067, 4-Amino-N,2-pyridinylbenzenesulfonamide, NSC-4753, Y5V2N1KE8U, NSC-41791, CHEBI:132842, DTXCID206067, Sulphapyridin, 4-((2-Pyridylamino)sulfonyl)aniline, Sulfanilamidopyridine, Concord 693, RefChem:58273, J01EB04, M&B693, 205-642-7, N1-2-Pyridylsulfanilamide, 4-amino-N-(pyridin-2-yl)benzenesulfonamide, 2-(4-Aminobenzenesulfonamido)pyridine, N(sup1)-Pyridylsulfanilamide, Sulfapyridine-13C6, M + B 693, NSC 4753, Sulfasalazine EP Impurity J, NSC 41791, 4-AMINO-N-2-PYRIDINYLBENZENESULFONAMIDE, 4-amino-n-(2-pyridinyl)benzenesulfonamide, MFCD00038036, MLS000069725, A 499, NSC4753, NCGC00016408-01, CAS-144-83-2, SMR000058213, Solfapiridina [DCIT], WLN: T6NJ BMSWR DZ, 4-amino-N-(2-pyridyl)benzenesulfonamide, Sulfapyridinum [INN-Latin], Sulfapiridina [INN-Spanish], 2-Sulfanilamidopyridin [German], M and B 693, [(4-aminophenyl)sulfonyl]-2-pyridylamine, 4-Amino-n-2-pyridinyl-benzenesulfonamide, SR-01000000207, N'-2-Pyridylsulfanilide, EINECS 205-642-7, Sulfapyridine (USP/INN), UNII-Y5V2N1KE8U, ulfapyridine, AI3-01049, Sulfapyridine [USP:INN:BAN], sulfapyridine III, Sulfapyridine CRS, SFY, ALBB-006215, Prestwick_1015, Spectrum_000996, Sulfapyridine (Dagenan), Sulfapyridine (Standard), Prestwick0_000762, Prestwick1_000762, Prestwick2_000762, Prestwick3_000762, Spectrum2_001323, Spectrum3_001773, Spectrum4_000346, Spectrum5_001182, SULFAPYRIDINE [MI], CHEMBL700, Epitope ID:122235, EC 205-642-7, SULFAPYRIDINE [INN], cid_5336, Sulfapyridine, >=99.0%, Oprea1_344996, SCHEMBL44219, BSPBio_000804, BSPBio_003265, KBioGR_000751, KBioSS_001476, AO-801/41077453, DivK1c_000216, SPECTRUM1500551, SULFAPYRIDINE [MART.], SPBio_001445, SPBio_002743, SULFAPYRIDINE [USP-RS], SULFAPYRIDINE [WHO-DD], BPBio1_000886, orb1310311, orb3025064, SCHEMBL29438089, BDBM39340, GECHUMIMRBOMGK-UHFFFAOYSA-, GTPL12698, HMS500K18, HY-B0212R, KBio1_000216, KBio2_001476, KBio2_004044, KBio2_006612, KBio3_002766, MSK4003, NINDS_000216, 4-(2-Pyridinylsulfonyl)aniline #, HMS1570I06, HMS1921C03, HMS2092K05, HMS2097I06, HMS2233H20, HMS3372N13, HMS3714I06, HMS5087I17, Pharmakon1600-01500551, SULFAPYRIDINE [ORANGE BOOK], HY-B0212, NSC41791, SULFAPYRIDINE [USP IMPURITY], Tox21_110426, aniline, N-2-pyridyl-4-sulphamoyl-, CCG-39261, EBC-04140, MSK4003-100M, NSC757329, s1617, SBB003154, STK292439, SULFAPYRIDINE [USP MONOGRAPH], AKOS000121424, MSK4003-1000M, Tox21_110426_1, CS-2157, DB00891, FS27939, HS-0063, M&B-693, NSC-757329, IDI1_000216, UPCMLD0ENAT5889155:001, NCGC00016408-02, NCGC00016408-03, NCGC00016408-04, NCGC00016408-05, NCGC00016408-06, NCGC00016408-09, NCGC00016408-10, NCGC00022008-03, NCGC00022008-04, Sulfanilamide, N1-2(1H)-pyridylidene-, AC-26818, SBI-0051525.P003, SULFAPYRIDINE MELTING POINT STANDARD, DB-042750, AB00052100, NS00000225, ST45026614, EN300-21145, Sulfapyridine 1000 microg/mL in Acetonitrile, Sulfapyridine Solution in Methanol, 100ug/mL, SULFASALAZINE IMPURITY J [EP IMPURITY], D02434, Sulfapyridine Solution in Methanol, 1000ug/mL, AB00052100_14, AB00052100_15, benzenesulfonamide, 4-amino-N(S)-(2-pyridyl)-, F358283, Sulfapyridine, VETRANAL(TM), analytical standard, Q3976827, SR-01000000207-2, SR-01000000207-3, BRD-K41406082-001-05-5, BRD-K41406082-001-09-7, BRD-K41406082-001-15-4, BRD-K41406082-001-16-2, Z104492884, 4-amino-N-(1,2-dihydropyridin-2-ylidene)benzenesulfonamide, Sulfapyridine, European Pharmacopoeia (EP) Reference Standard, 4-Amino-N-(pyrimidin-2-yl) benzenesulfonamide (Sulfadiazine) (14), Sulfapyridine, United States Pharmacopeia (USP) Reference Standard, Sulfapyridine Melting Point Standard, United States Pharmacopeia (USP) Reference Standard, InChI=1/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14), Sulfapyridine melting point standard, Pharmaceutical Secondary Standard, Certified Reference Material